Fever after immunization: Current concepts and improved future scientific understanding

Clinical Infectious Diseases

Volumn 39, Issue 3, 2004, Pages 389-394

  Kohl, Katrin S ^a   Marcy, S Michael ^b,c   Blum, Michael ^f   Jones, Marcy Connell ^e   Dagan, Ron ⁱ   Hansen, John ^d   Nalin, David ^c,g   Rothstein, Edward ^h  

^a CENTERS FOR DIS CONTR AND PREV   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c Department of Pediatrics ^*  (United States)

^d KAISER PERMANENTE   (United States)

^e CALIFORNIA DEPARTMENT OF PUBLIC HEALTH   (United States)

^f PFIZER INC   (United States)

^g MERCK RESEARCH LABORATORIES   (United States)

^h Pennridge Pediatrics Associates   (United States)

ⁱ BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; DIPHTHERIA PERTUSSIS TETANUS VACCINE; IBUPROFEN; MEASLES MUMPS RUBELLA VACCINE; PARACETAMOL; POLIOMYELITIS VACCINE; VACCINE;

AGE; BODY TEMPERATURE; CLINICAL TRIAL; DRUG SAFETY; ECONOMIC ASPECT; FEBRILE CONVULSION; FEVER; HEALTH ECONOMICS; HEALTH SURVEY; HUMAN; IMMUNIZATION; PRACTICE GUIDELINE; PRIORITY JOURNAL; RECTUM TEMPERATURE; REVIEW; TEMPERATURE MEASUREMENT; THERMOMETER;

ADULT; CHILD; FEVER; HUMANS; INFANT; SEIZURES, FEBRILE; VACCINATION;

EID: 3943107534     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/422454     Document Type: Review

References (59)

1. Mackowiak PA. Concepts of fever. Arch Intern Med 1998; 158:1870-81.
2. McCarthy PL. Fever. Pediatr Rev 1998; 19:401-7.
3. Bouchama A, Knochel JP. Heat stroke. N Engl J Med 2002; 346:1978-88.
4. Simon HB. Hyperthermia. N Engl J Med 1993; 329:483-7.
5. Wunderlich CRA. Das Verhalten der Eigenwärme in Krankheiten. Leipzig: Otto Wiegard, 1868.
6. Mackowiak PA, Worden G. Carl Reinhold August Wunderlich and the evolution of clinical thermometry. Clin Infect Dis 1994; 18:458-67.
7. Mackowiak PA, Boulant JA. Fever's glass ceiling. Clin Infect Dis 1996; 22:525-36.
8. Dinarello CA. Thermoregulation and the pathogenesis of fever. Infect Dis Clin North Am 1996; 10:433-49.
9. Benzinger TH. Clinical temperature: new physiological basis. JAMA 1969; 209:1200-6.
10. Robinson JL, Seal RF, Spady DW, Joffres MR. Comparison of esophageal, rectal, axillary, bladder, tympanic, and pulmonary artery temperatures in children. J Pediatr 1998; 133:553-6.
11. Romano MJ, Fortenberry JD, Autrey E, et al. Infrared tympanic thermometry in the pediatric intensive care unit. Crit Care Med 1993; 21: 1181-5.
12. Craig JV, Lancaster GA, Taylor S, et al. Infrared ear thermometry compared with rectal thermometry in children: a systematic review. Lancet 2002; 360:603-9.
13. Craig JV, Lancaster GA, Williamson PR, Smyth RL. Temperature measured at the axilla compared with rectum in children and young people: systematic review. Br Med J 2000; 320:1174-8.
14. Brown RD, Kearns G, Eichler VF, Wilson JT. A probability nomogram to predict rectal temperature in children. Clin Pediatr 1992; 31:523-31.
15. Leick-Rude MK, Bloom LF. A comparison of temperature-taking methods in neonates. Neonatal Netw 1998; 17:21-37.
16. Crocetti M, Moghbeli N, Serwint J. Fever phobia revisited: have parental misconceptions about fever changed in 20 years? Pediatrics 2000; 107:1241-6.
17. Ipp M, Jaffe D. Physicians' attitudes toward the diagnosis and management of fever in children 3 months to 2 years of age. Clin Pediatr 1993; 32:66-70.
18. Kramer MS, Naimark L, Leduc DG. Parental fever phobia and its correlates. Pediatrics 1985; 75:1110-3.
19. Wittler RR, Cain KK, Bass JW. A survey about management of febrile children without source by primary care physicians. Pediatr Infect Dis J 1998; 17:271-7.
20. Schmitt BD. Fever phobia: misconceptions of parents about fevers. Am J Dis Child 1980; 134:176-81.
21. Van der Jagd EW. Fever. In: Hoekelman RA, ed. Primary pediatric care. 3rd ed. St. Louis: CV Mosby & Co, 1997:959-66.
22. Villarreal SF, Berman S, Groothuis JR, et al. Telephone encounters in a university pediatric group practice: a 2-year analysis of after-hours calls. Clin Pediatr 1984; 23:456-8.
23. Schmitt BD. Fever in childhood. Pediatrics 1984; 74:929-36.
24. Bonadio WA, Romine K, Gyuro J. Relationship of fever magnitude to rate of serious bacterial infections in neonates. J Pediatr 1990; 116:733-5.
25. Luszczak M. Evaluation and management of infants and young children with fever. Am Fam Physician 2001; 64:1219-26.
26. Baraff LJ, Bass JW, Fleischer GR, et al. Practice guideline for the management of infants and children O to 36 months of age with fever without source. Ann Emerg Med 1993; 22:1198-1210.
27. Kline MW, Lorin MI. Bacteremia in children afebrile at presentation to an emergency room. Pediatr Infect Dis J 1987; 6:197-8.
28. Bonadio WA, Hegenbarth M, Zachariason M. Correlating reported fever in young infants with subsequent temperature patterns and rate of serious bacterial infections. Pediatr Infect Dis J 1990; 9:158-60.
29. Slater M, Krug SE. Evaluation of the infant with fever without source: an evidence based approach. Emerg Med Clin North Am 1999; 17:97-126.
30. Baker RC, Tiller T, Bausher JC, et al. Severity of disease correlated with fever reduction in febrile infants. Pediatrics 1989; 83:1016-9.
31. Ruuskanen O, Heikkinen T. Otitis media: etiology and diagnosis. Pediatr Infect Dis J 1994; 13(Suppl):S23-6.
32. Bonadio WA. The history and physical assessments of the febrile infant. Pediatr Clin North Am 1998; 45:65-77.
33. Roberts JD, Roos LL, Poffenroth LA, et al. Surveillance of vaccine-related adverse events in the first year of life: a Manitoba cohort study. J Clin Epidemiol 1996; 49:51-8.
34. World Health Organization. Supplementary information on vaccine safety: part 2. Background rates of adverse events following immunization. Geneva: World Health Organization, Department of Vaccine and Biologicals, 2000. Available from: http://www.who.int/vaccines-documents/. Accessed on 7 July 2004.
35. Lieu TA, Black SB, Ray GT, et al. The hidden costs of infant vaccination. Vaccine 2000; 19:33-41.
36. Lewis K, Cherry JD, Sachs MH, et al. The effect of prophylactic acetaminophen administration on reactions to DTP vaccination. Am J Dis Child 1988; 142:62-5.
37. Ipp MM, Gold R, Greenberg S, et al. Acetaminophen prophylaxis of adverse reactions following vaccination of infants with diphtheria-pertussis-tetanus toxoids-polio vaccine. Pediatr Infect Dis J 1987; 6:721-5.
38. Centers for Disease Control and Prevention. Pertussis vaccination: use of acellular pertussis vaccines among infants and young children-recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR 1997; 46(RR-7):19. Available at: http://www.cdc.gov/mmwr/preview/mmwrhtml/00048610. htm. Accessed on 7 July 2004.
39. Hirtz DG. Febrile seizures. Pediatr Rev 1997; 18:5-8.
40. Barlow WE, Davis RL, Glasser JW, et al. The risk of seizures after receipt of whole-cell pertussis or measles, mumps, and rubella vaccine. N Engl J Med 2001; 345:656-61.
41. Annegers JF, Hauser WA, Shirts SB, Kurland LT. Factors prognostic of unprovoked seizures after febrile convulsions. N Engl J Med 1987; 316: 493-8.
42. Nelson KB, Ellenberg JH. Predictors of epilepsy in children who have experienced febrile seizures. N Engl J Med 1976; 295:1029-33.
43. Verity CM, Butler NR, Golding J. Febrile convulsions in a national cohort followed up from birth. II. Medical history and intellectual ability at 5 years of age. Br Med J 1985; 290:1311-5.
44. Romanus V, Jonsell R, Bergquist SO. Pertussis in Sweden after the cessation of general immunization in 1979. Pediatr Infect Dis J 1987; 6: 364-71.
45. Liebert UG. Measles virus infections of the central nervous system. Intervirology 1997; 40:176-84.
46. Koskiniemi M, Korppi M, Mustonen K, et al. Epidemiology of encephalitis in children: a prospective multicentre study. Eur J Pediatr 1997; 156:541-5.
47. Funkhouser AW, Wassilak SG, Orenstein WA, Hinman AR, Mortimer EA Jr. Estimated effects of a delay in the recommended vaccination schedule for diphtheria and tetanus toxoids and pertussis vaccine. JAMA 1987; 257:1341-6.
48. Dagan R. Immunisation with a pneumococcal 7-valent conjugate vaccine. Int J Clin Pract 2002; 56:287-91.
49. Lee GM, Harper MB. Risk of bacteremia for febrile young children in the post-Haemophilus influenzae type b era. Arch Pediatr Adolesc Med 1998; 152:624-8.
50. Alpern ER, Alessandrini EA, Bell LM, et al. Occult bacteremia from a pediatric emergency department: current prevalence, time to detection, and outcome. Pediatrics 2000; 106:505-1.
51. Centers for Disease Control and Prevention. Progress toward elimination of Haemophilus influenzae type b invasive disease among infants and children - United States, 1998-2000. MMWR Morb Mortal Wkly Rep 2002; 51:234-7.
52. Miller D, Wadsworth J, Diamond J, Ross E. Pertussis vaccine and whooping cough as risk factors in acute neurological illness and death in young children. Dev Biol Stand 1985; 61:389-94.
53. National Institute of Health. Medical encyclopedia. 10 November 2003. Available at: http://www.nlm.nih.gov/medlineplus/ency/article/003090 .htm. Accessed on 7 July 2004.
54. Virtanen M, Peltola H, Paunio M, Heinonen OP. Day-to-day reactogenicity and the healthy vaccinee effect of measles-mumps-rubella vaccination. Pediatrics 2000; 106:E62.
55. Peltola H, Heinonen OP. Frequency of true adverse reactions to measles-mumps-rubella vaccine: a double-blind placebo-controlled trial in twins. Lancet 1986; 1:939-942.
56. Weibel RE, Neff BJ, Kuter BJ, et al. Live attenuated varicella virus vaccine: efficacy trial in healthy children. N Engl J Med 1984; 310: 1409-15.
57. Werzberger A, Mensch B, Kuter B, et al. A controlled trial of a formalin-inactivated hepatitis A vaccine in healthy children. N Engl J Med 1992; 327:453-7.
58. Belshe RB, Mendelman PM, Treanor J, et al. The efficacy of live attenuated, cold-adapted, trivalent, intranasal influenzavirus vaccine in children. N Engl J Med 1998; 338:1405-12.
59. Bonhoeffer J, Kohl K, Chen R, et al. The Brighton Collaboration: addressing the need for standardized case definitions of adverse events following immunization (AEFI). Vaccine 2002; 21:298-302.